GOS (Galacto-Oligosaccharides)

Evidence Level
Moderate
2 Clinical Trials
6 Documented Benefits
3/5 Evidence Score

Galacto-oligosaccharides (GOS) are prebiotic fibers consisting of 2-8 galactose units with terminal glucose — produced enzymatically from lactose. Related galactose sugars occur naturally in human breast milk and in small amounts in some legumes, but the GOS in supplements and formulas is not taken from milk. It is built in a factory from lactose. Commercially produced from cow's milk lactose using β-galactosidase. Some studies suggest it feeds bifidobacteria at least as well as FOS, which is one reason it is added to many infant formulas.

Studied Dose Cited studies used 5 g a day (calcium absorption) and 15 g a day (prediabetes); products commonly supply 2.5 to 15 g a day.
Active Compound Galacto-oligosaccharides (mixed DP 2-8; β(1-4) and β(1-6) galactose linkages with terminal glucose).

Benefits

Strong Bifidogenic Effect (Infant and Adult)

This is the best supported effect. In healthy adults, GOS raised stool bifidobacteria in a dose-dependent way (Davis 2010). Added to infant formula, it raised bifidobacteria and lactobacilli in infants (Ben 2008). In a 12-week trial in 44 overweight adults with prediabetes taking 15 g a day, bifidobacteria rose about 5-fold, yet that same trial found no change in insulin sensitivity, body composition, short-chain fatty acids, gut hormones or inflammation markers (Canfora 2017). A separate crossover trial in adolescent girls taking 5 g a day found more bifidobacteria plus better calcium absorption (Whisner 2013). So the bacterial shift is real and repeatable, but a change in gut bacteria is a laboratory measurement, not by itself a proven health benefit.

Infant Formula Fortification (Standard Component)

Many infant formulas include GOS, often combined with FOS, to copy part of what the oligosaccharides in breast milk do. The study cited here (Ben 2008) found that a low level of GOS in formula raised intestinal bifidobacteria and lactobacilli in infants, which is a bacterial measurement rather than a health outcome. No trial cited on this page tested stool problems or constipation in formula-fed infants. Infant feeding decisions belong with a pediatrician.

Constipation Relief (Not Tested In The Studies Cited Here)

This page cites no constipation trial, so treat the claim as unverified. Prebiotic fibers draw water into the bowel and are fermented by gut bacteria, which is the usual reasoning behind the idea, but none of the four studies listed below measured stool frequency or consistency. Ongoing constipation is worth discussing with a doctor.

Travelers' Diarrhea (No Cited Trial)

No travelers' diarrhea trial appears in this page's reference list, so this claim is unverified here. The proposed idea is that GOS may bind some gut bacteria and support the gut lining, but nothing in the studies cited below tested infection or diarrhea in people.

Allergy / Atopy Prevention (Mixed Evidence)

Some trials in infants have linked a GOS plus FOS mixture to less atopic dermatitis, and later research has been mixed. Two cautions: those studies tested a combination rather than GOS on its own, and none of them are cited on this page.

Anxiety and Stress (No Cited Trial)

Some gut-brain research has looked at prebiotics and stress markers, but no such trial is cited on this page, and none of the four studies listed below measured mood, stress hormones or attention. Treat this as an unproven idea rather than a reason to take GOS.

Mechanism of action

1

Bifidobacterium-Selective Fermentation

GOS is preferentially fermented by Bifidobacterium species (particularly B. infantis, B. longum, B. breve). β-galactosidase activity in Bifidobacterium efficiently cleaves GOS. Result: significant Bifidobacterium expansion.

2

Mimics Human Milk Oligosaccharide Function

Human breast milk contains HMOs (human milk oligosaccharides) — complex fingerprint of ~200 different oligosaccharides supporting infant microbiome and immunity. GOS is much simpler than those milk sugars and copies only part of what they do, mainly feeding bifidobacteria. That is the reasoning behind adding it to infant formula.

3

Pathogen Exclusion / Decoy Receptor Effect

In laboratory work, GOS may act as a decoy that some gut bacteria stick to instead of sticking to the gut wall. This is a proposed mechanism only. No study cited on this page tested infection or diarrhea in people.

4

SCFA Production (Same as FOS)

Gut bacteria can ferment GOS into short-chain fatty acids such as acetate, propionate and butyrate, which are thought to feed the cells lining the colon. Worth knowing: the 12-week trial in adults with prediabetes measured short-chain fatty acids in both stool and blood and found no change, so this step does not reliably show up at the doses studied.

Clinical trials

1
GOS for Infant Microbiome

Randomized trial of a low level of GOS added to infant formula versus standard formula (Ben 2008, PMID 19030213), measuring stool bacteria.

Formula-fed infants.

Infants on the GOS formula had more bifidobacteria and lactobacilli in stool, closer to a breast-fed profile. Limitations: the sample was small, it measured bacteria rather than any health outcome such as illness or growth, and it was done in infants, so it says nothing about what GOS does for adults.

2
GOS in Adults With Prediabetes (12 Weeks)

Randomized placebo-controlled trial of 15 g a day of GOS for 12 weeks, published in Gastroenterology (Canfora 2017, PMID 28396144).

44 overweight or obese adults aged 45 to 70 with prediabetes.

Bifidobacteria rose about 5-fold (p = 0.009). Nothing else moved: the researchers reported no differences in stool or blood short-chain fatty acids, gut hormones including incretins, inflammation markers, insulin sensitivity, body composition, or energy and substrate metabolism. The paper's own title says it plainly, increases bifidobacteria but not insulin sensitivity. Because this was done in people with prediabetes, it does not describe what GOS does for a healthy person.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Gas and bloating, which some people find milder than with FOS.
Abdominal discomfort at higher doses.
Diarrhea or loose stools at very high doses (osmotic).
Galactosemia — rare genetic disorder of galactose metabolism; avoid (life-threatening).
FODMAP component (lactose-derived) — IBS sensitivity in some.
Lactose contamination minor concern — most GOS products tested for low/no lactose.

Important Drug interactions

Generally minimal drug interactions.
Galactosemia — contraindicated.
Antibiotics: no direct drug interaction is known. Whether GOS helps the microbiome recover after antibiotics was not tested in any study cited here.
Diabetes medications — minimal interactions.
Pregnancy/lactation — generally safe; widely used in food and infant formulas.
Lactose intolerance — GOS production may leave trace lactose; commercial products typically tested low; severe lactose intolerance verify product.

Frequently asked questions about GOS (Galacto-Oligosaccharides)

What is GOS (galactooligosaccharides)?

GOS are prebiotic fibers made from lactose (milk sugar) using an enzyme. They are similar in structure to some of the sugars in breast milk, though they are not the same molecules. They pass through digestion largely intact and are fermented by gut bacteria, especially bifidobacteria.

What is GOS used for?

GOS is used as a prebiotic. What the studies cited here actually show is that it increases bifidobacteria in healthy adults, in infants fed fortified formula, and in adolescent girls, where it also increased calcium absorption. It is added to some infant formulas for that same bacterial reason. Claims about immune function, constipation, travelers' diarrhea and stress are not backed by any study cited on this page.

Does GOS cause digestive issues?

Like other prebiotics, GOS can cause gas or bloating at higher amounts due to fermentation, though some people tolerate it better than FOS or inulin. Start low and increase gradually. It is a FODMAP for sensitive individuals.

Is GOS safe?

GOS has a long record of use in foods and infant formulas and is well tolerated by most people. Digestive comfort is the main limit, so those with IBS or FODMAP sensitivity should start small. People with galactosemia must avoid it. If you are pregnant, nursing, giving it to an infant, or managing a medical condition, check with your doctor first.

What is GOS?

Galacto-oligosaccharides (GOS) are prebiotic fibers consisting of 2-8 galactose units with terminal glucose — produced enzymatically from lactose. Related galactose sugars occur naturally in human breast milk and in small amounts in some legumes, but the GOS in supplements and formulas is not taken from milk.

What is the recommended dosage of GOS?

The clinically studied dose is Cited studies used 5 g a day (calcium absorption) and 15 g a day (prediabetes); products commonly supply 2.5 to 15 g a day. Always follow the product label and check with a healthcare provider for personal advice.

Is GOS safe, and does it have side effects?

For most healthy adults, GOS is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Gas and bloating, which some people find milder than with FOS. It may also interact with some medications. GOS is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does GOS interact with any medications?

Possible interactions include: Generally minimal drug interactions. Galactosemia — contraindicated. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for GOS?

NutraSmarts rates the evidence for GOS as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Davis LM, Martinez I, Walter J, Hutkins R A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults Int J Food Microbiol. 2010;144(2):285-92. doi: 10.1016/j.ijfoodmicro.2010.10.007.PubMedUsed to support: Backs the bifidogenic prebiotic claim: GOS increased fecal bifidobacteria in healthy adults in a dose-dependent manner. Honesty: this is a microbiota-shift study (surrogate endpoint), not a clinical health-outcome trial, and higher doses drive more GI gas.
  2. Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, et al. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals Gastroenterology. 2017;153(1):87-97.e3. doi: 10.1053/j.gastro.2017.03.051.PubMedUsed to support: Backs the bifidogenic claim while supplying the honest counterpoint: a 12-week RCT in obese prediabetic adults found GOS significantly increased fecal bifidobacteria but did not improve insulin sensitivity, body composition, or other metabolic markers. Honesty: the microbiome shift is real, but it did not translate into a metabolic benefit.
  3. Ben XM, Li J, Feng ZT, Shi SY, Lu YD, Chen R, Zhou XY Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli World J Gastroenterol. 2008;14(42):6564-8. doi: 10.3748/wjg.14.6564.PubMedUsed to support: Backs the bifidogenic prebiotic claim in the infant-formula context: adding GOS to formula increased intestinal Bifidobacteria and Lactobacilli toward a breast-fed-like profile. Honesty: a surrogate microbiota endpoint (not a clinical outcome), in infants, with a small sample.
  4. Whisner CM, Martin BR, Schoterman MH, Nakatsu CH, McCabe LD, McCabe GP, Wastney ME, van den Heuvel EG Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial Br J Nutr. 2013;110(7):1292-303. doi: 10.1017/S000711451300055X.PubMedUsed to support: Backs the calcium-absorption claim: 5 g/day GOS increased fractional calcium absorption and fecal bifidobacteria in adolescent girls. Honesty: effect on absorption was not strictly dose-proportional, the sample was small, and a downstream bone-mass benefit was inferred, not directly measured.